Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

C. Levy; J. A. Peter; D. R. Nelson; J. Keach; J. Petz; R. Cabrera; V. Clark; R. J. Firpi; G. Morelli; C. Soldevila-Pico; K. Lindor

首页> 外文期刊>Alimentary Pharmacology & Therapeutics >Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

【24h】

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

机译：先导研究：非诺贝特用于原发性胆汁性肝硬化且对熊去氧胆酸反应不完全的患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aliment Pharmacol Ther 2011; 33: 235–242

机译：Aliment Pharmacol Ther 2011； 33：235–242

著录项

来源
《Alimentary Pharmacology & Therapeutics》 |2011年第2期|235-242|共8页
作者
C. Levy; J. A. Peter; D. R. Nelson; J. Keach; J. Petz; R. Cabrera; V. Clark; R. J. Firpi; G. Morelli; C. Soldevila-Pico; K. Lindor;
展开▼
作者单位

Division of Gastroenterology Hepatology and Nutrition Department of Medicine University of Florida Gainesville FL USA.;

Division of Gastroenterology and Hepatology Mayo Clinic Foundation Rochester MN USA.;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. [J] . Levy C, Peter JA, Nelson DR, Alimentary pharmacology & therapeutics. . 2011,第2期

机译：初步研究：非诺贝特用于原发性胆汁性肝硬化且对熊去氧胆酸反应不完全的患者。
2. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to?UDCA monotherapy: a meta-analysis [J] . Yan Zhang, Sainan Li, Lei He, Drug Design, Development and Therapy . 2015,第9期

机译：原发性胆汁性肝硬化患者对UDCA单药治疗反应不完全的非诺贝特和熊去氧胆酸联合治疗：一项荟萃分析
3. The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study. [J] . Leuschner M, Holtmeier J, Ackermann H, European journal of gastroenterology and hepatology . 2002,第12期

机译：舒林酸对原发性对熊去氧胆酸反应不完全的原发性胆汁性肝硬化患者的影响：一项初步研究。
4. Ursodeoxycholic Acid therapy Affects the Cytokine Network and Plays An Immunomodulatory Role in Patients With Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis [C] . M. G. Neuman, P. Angulo, I. M. Malkiewicz, Falk Symposium . 2003

机译：核糖核酸酸治疗影响细胞因子网络，并对初级硬化胆管炎和原发性胆汁肝硬化患者发挥免疫调节作用
5. Predicting outcomes post liver transplantation in patients with primary biliary cirrhosis and primary sclerosing cholangitis. [D] . Zapatochny Rufo, Rebecca Jo. 2003

机译：预测原发性胆汁性肝硬化和原发性硬化性胆管炎患者肝移植后的结局。
6. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis [O] . Yan Zhang, Sainan Li, Lei He, 2015

机译：非诺贝特联合熊去氧胆酸联合治疗对UDCA单一疗法反应不完全的原发性胆汁性肝硬化患者的荟萃分析
7. Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid [O] . C. Levy, J. A. Peter, D. R. Nelson, 2010

机译：试点研究：对原发性胆汁肝硬化患者的芬非纤维酸酯和对熊胆酸胆酸的不完全反应

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

摘要

著录项

相似文献

相关主题

期刊订阅